Knights, Ashley J <br/><br/>
Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Feb 2013 
 - 321-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0851 
<br/><br/><label>Standard No.: </label>10.1007/s00262-012-1342-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Neoplasm--immunology<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cancer Vaccines--pharmacology<br/>Cells, Cultured<br/>Combined Modality Therapy<br/>Cytokines--metabolism<br/>Dendritic Cells--drug effects<br/>Humans<br/>Immunotherapy<br/>Inhibitor of Apoptosis Proteins--antagonists & inhibitors<br/>Leukocytes, Mononuclear--drug effects<br/>NF-kappa B--metabolism<br/>Peptides--pharmacology<br/>T-Lymphocytes--drug effects<br/>Thiazoles--pharmacology<br/>Up-Regulation--drug effects